Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ: MIDD ) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. • Target Hospitality (NASDAQ: TH ) is projected to report earnings for its first quarter. • Hudson Global (NASDAQ: HSON ) is projected to report earnings for its first quarter. • Maiden Hldgs (NASDAQ: MHLD ) is estimated to report earnings for its first quarter. • WhiteHorse Finance (NASDAQ: WHF ) is likely to report earnings for its first quarter. • Anavex Life Sciences (NASDAQ: AVXL ) is estimated to report earnings for its second quarter. • Eos Energy Enterprises (NASDAQ: EOSE ) is estimated to report quarterly loss at $0.56 per share on revenue of $4.32 million. • Navios Maritime Partners (NYSE: NMM ) is estimated to report quarterly earnings at $3.49 per share on revenue of $225.48 million. • Exela Technologies (NASDAQ: XELA ) is expected to report quarterly loss at $0.10 per share on revenue of $284.91 million. • Reata Pharmaceuticals (NASDAQ: RETA ) is likely to report quarterly loss at $2.
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ: MIDD ) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. • Target Hospitality (NASDAQ: TH ) is projected to report earnings for its first quarter. • Hudson Global (NASDAQ: HSON ) is projected to report earnings for its first quarter. • Maiden Hldgs (NASDAQ: MHLD ) is estimated to report earnings for its first quarter. • WhiteHorse Finance (NASDAQ: WHF ) is likely to report earnings for its first quarter. • Anavex Life Sciences (NASDAQ: AVXL ) is estimated to report earnings for its second quarter. • Eos Energy Enterprises (NASDAQ: EOSE ) is estimated to report quarterly loss at $0.56 per share on revenue of $4.32 million. • Navios Maritime Partners (NYSE: NMM ) is estimated to report quarterly earnings at $3.49 per share on revenue of $225.48 million. • Exela Technologies (NASDAQ: XELA ) is expected to report quarterly loss at $0.10 per share on revenue of $284.91 million. • Reata Pharmaceuticals (NASDAQ: RETA ) is likely to report quarterly loss at $2.